FDA Clearance Tracker · P060002-S006
BARD FLAIR ENDOVASCULAR STENT GRAFT
Last checked: Nov 20, 2026Latest source record: May 18, 2010 (this decision)Source: openFDAMethods & limitations
Decided
May 18, 2010
Approved
Time to decision
230 days
Received Sep 30, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P060002-S006
- Device name
- BARD FLAIR ENDOVASCULAR STENT GRAFT
- Applicant
- Bard Peripheral Vascular
- Applicant location
- Tempe, AZ
- Received
- Sep 30, 2009
- Decided
- May 18, 2010
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P060002
Device type
- Device type
- System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL PROTOCOL.
Source documents
Other decisions for Bard Peripheral Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250050 · Decided Sep 25, 2026 · 303 days after receipt
Device type: SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS (MIR) · Cardiology
K262571 · Decided Aug 14, 2026 · 21 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
K260012 · Decided Feb 4, 2026 · 30 days after receipt
Device type: Catheter, Percutaneous, Cutting/Scoring (PNO) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.